Sunshine Biopharma (SBFM) Operating Margin Growth (3y) (2021 - 2026)
Sunshine Biopharma (SBFM) Operating Margin Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 1,673.00 |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | -37.00 |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -5,395.00 |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | -1,442.00 |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | -1,299.00 |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 5,091.00 |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 5,193.00 |
| 10 | Sunshine Biopharma | 750,608.81 | -6.16 Mn | 2.18 Mn | 2,012.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,012.00 |
| Dec 31, 2025 | 57,214.00 |
| Sep 30, 2025 | 128,204.00 |
| Jun 30, 2025 | 44,108.00 |
| Mar 31, 2025 | 98,293.00 |
| Dec 31, 2024 | 30,728.00 |
| Sep 30, 2024 | 97,199.00 |
| Jun 30, 2024 | 72,132.00 |
| Mar 31, 2024 | 316,659.00 |
| Dec 31, 2023 | 121,011.00 |
| Sep 30, 2023 | 37,927.00 |
| Jun 30, 2023 | 83,069.00 |
| Mar 31, 2023 | 30,220.00 |
| Dec 31, 2022 | 178,090.00 |
| Sep 30, 2022 | 147,246.00 |
| Jun 30, 2022 | 171,964.00 |
| Mar 31, 2022 | 5.83 Mn |
| Mar 31, 2021 | -300,165.00 |